Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 30, 2020
The United States Alpha-1 Foundation Research Registry: Genesis, Impact and Future.
Journal: COPD
Published: May 05, 2015
Inhaled alpha 1-antitrypsin: gauging patient interest in a new treatment.
Journal: COPD
Published: March 30, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026